Federal contract award
75N91021P00878
MOLECULAR MODELING SOFTWARE USED TO DESIGN THE NEXT GENERATION OF THERAPEUTICS AGAINST HIV, VARIOUS CANCERS, SARS-COV2, AND VARIOUS OTHER THERAPEUTIC TARGETS OF INTEREST TO MANY NIH INVESTIGATORS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 511210 |
| PSC | 7A21 — Business Application off-the-shelf software delivered by perpetual license, which also encompasses enterprise level software enabling mission capability and business operational support. |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $684.0K |
| Current contract value | $684.0K |
| Potential contract value / ceiling | $684.0K |
| Start date | Sep 15, 2021 |
| Current end date | Aug 31, 2026 |
| Potential end date | Aug 31, 2026 |
| Latest award activity | Mar 16, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 16, 2026 | P00005 | $-0 | TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Jun 30, 2025 | P00004 | $31.1K | TWO (2) MONTH EXTENSION UNDER FAR CLAUSE 52.217-8 (OPTION TO EXTEND SERVICES) - MOLECULAR MODELING SOFTWARE USED TO DESIGN THE NEXT GENERATION OF THERAPEUTICS AGAINST HIV, VARIOUS CANCERS, SARS-COV2, AND VARIOUS OTHER THERAPEUTIC TARGETS OF INTEREST |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.